urea has been researched along with Epilepsy, Temporal Lobe in 8 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Epilepsy, Temporal Lobe: A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind cross-over trial between pheneturide and phenytoin in ninety-four outpatients with epilepsy is described." | 9.05 | A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial. ( Engler, C; English, JR; Fry, DE; Gawel, MJ; Gibberd, FB; Page, NG; Park, DM; Rose, FC; Scott, G, 1982) |
| "A double-blind cross-over trial between pheneturide and phenytoin in ninety-four outpatients with epilepsy is described." | 5.05 | A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial. ( Engler, C; English, JR; Fry, DE; Gawel, MJ; Gibberd, FB; Page, NG; Park, DM; Rose, FC; Scott, G, 1982) |
| " Creatinine concentrations should not be considered when dosage adjustments of renally eliminated drugs are being calculated for patients with such metabolic interferences." | 1.29 | Creatinine metabolism impairment by an anticonvulsant drug, phenacemide. ( Baltassat, P; Cahen, R; Francois, B; Louisot, P; Martin, A, 1994) |
| "Phenacemide therapy was well tolerated with a minimum of untoward side effects and no evidence of irreversible drug toxicity." | 1.27 | Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations. ( Coker, SB; Egel, RT; Holmes, EW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godoy, LD | 2 |
| Liberato, JL | 2 |
| Celani, MVB | 1 |
| Gobbo-Neto, L | 1 |
| Lopes, NP | 2 |
| Dos Santos, WF | 2 |
| Cunha, AOS | 1 |
| Mortari, MR | 1 |
| de Oliveira Beleboni, R | 1 |
| Fontana, ACK | 1 |
| Bilikiewicz, T | 1 |
| Gromska, J | 1 |
| Vas, CJ | 1 |
| Parsonage, MJ | 1 |
| Gibberd, FB | 1 |
| Park, DM | 1 |
| Scott, G | 1 |
| Gawel, MJ | 1 |
| Fry, DE | 1 |
| Page, NG | 1 |
| Engler, C | 1 |
| English, JR | 1 |
| Rose, FC | 1 |
| Cahen, R | 1 |
| Martin, A | 1 |
| Francois, B | 1 |
| Baltassat, P | 1 |
| Louisot, P | 1 |
| Coker, SB | 1 |
| Holmes, EW | 1 |
| Egel, RT | 1 |
| Hershon, HI | 1 |
| Parsonage, M | 1 |
2 trials available for urea and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Clinical Trials as Topic; Double-Blind Method; Epilepsies, | 1982 |
Comparative trial of diazepam and pheneturide in treatment of epilepsy.
Topics: Age Factors; Diazepam; Epilepsy; Epilepsy, Temporal Lobe; Female; Humans; Male; Stress, Psychologica | 1969 |
6 other studies available for urea and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Mal | 2017 |
Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy.
Topics: Animals; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Male; Neurons; Neuroprotectiv | 2018 |
[In defense of phenyl-acetylurea (Neophenal)].
Topics: Anticonvulsants; Epilepsy, Temporal Lobe; Humans; Urea | 1967 |
Treatment of intractable temporal lobe epilepsy with pheneturide.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Ataxia; Child; Epilepsy, Temporal Lobe; Hu | 1967 |
Creatinine metabolism impairment by an anticonvulsant drug, phenacemide.
Topics: Adult; Anticonvulsants; Benzeneacetamides; Carbamazepine; Creatinine; Epilepsy, Temporal Lobe; Glome | 1994 |
Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations.
Topics: Adolescent; Benzeneacetamides; Child; Child, Preschool; Epilepsy, Temporal Lobe; Female; Humans; Mal | 1987 |